Monoclonal antibodies (MAbs) are valuable tools for biological research, diagnostic immunoassays, and therapeutic purposes. In research, MAbs are used in a variety of techniques, including popular applications such as flow cytometry, western blotting, enzyme-linked immunosorbent assays (ELISA), and immunohistology.
Since Kohler & Milstein developed hybridoma technology in 1975, tens of thousands of monoclonal antibodies have been developed and produced against a variety of biological targets. You can also get more information about monoclonal antibodies via https://www.bosterbio.com/featured-products.
The successful use of monoclonal antibodies in biological studies is mainly due to the specificity and homogeneity of antibodies produced by hybridomas and the potential to produce an unlimited number of specific Mab.
Image Source: Google
Many companies offer a wide variety of monoclonal antibodies. The product range includes high-quality antibodies for research against viral antigens and CD markers of potential diagnostic and therapeutic importance.
A type of protein made in a laboratory that can bind to substances in the body, including cancer cells. There are many types of monoclonal antibodies. Monoclonal antibodies should only bind to one substance. Monoclonal antibodies are used to treat certain types of cancer. They can be used alone or deliver drugs, toxins, or radioactive materials directly to cancer cells.
Monoclonal antibodies (mAb) are identical immunoglobulins produced by single B cell clones. These antibodies recognize a unique epitope or binding site on the antigen. The production of individual B cell clones and subsequent targeting of a single epitope distinguish monoclonal antibodies from polyclonal antibodies.